Sfoglia per Autore
Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease.
2004 CONTIN M; MARTINELLI P; MOCHI M; ALBANI F; RIVA R; SCAGLIONE C; DONDI M; FANTI S; PETTINATO C; BARUZZI A.
18F-FDG PET early after radiotherapy in lymphoma patients.
2004 CASTELLUCCI P; ZINZANI P; NANNI C; FARSAD M; MORETTI A; ALINARI L; BATTISTA G; PETTINATO C; MARENGO M; BOSCHI S; CANINI R; BACCARANI M.; MONETTI N; FANTI S.
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients.
2004 ZINZANI PL; FANTI S; BATTISTA G; TANI M; CASTELLUCCI P; STEFONI V; ALINARI L; FARSAD M; MUSURACA G; GABRIELE A; MARCHI E; NANNI C; CANINI R.; MONETTI N; BACCARANI M
Does technetium-99m diethylenetriaminepentaacetate clearance predict the clinical course of idiopathic pulmonary fibrosis?
2004 Mura M.; Belmonte G.; Fanti S.; Pacilli A.M.G.; Fasano L.; Zompatori M.; Schiavina M.; Fabbri Mario.
Sextant localization of prostate cancer with 11-C-choline PET/CT: comparison with three-dimensional proton MR spectroscopic imaging using step section histopathology as standard of references
2005 MARTORANA G.;SCHIAVINA R.;BRUNOCILLA E.;BERTACCINI A.;MANFERRARI F.;CONCETTI S.;FRANCESCHELLI A.;MONETTI N.;CASTELLUCCI P.;FARSAD M.;FANTI S.;CANINI R.;SALIZZONI E.;BARBIROLI B.;LODI R.;TESTA C.;CORTI B.;GRIGIONI W.F.
Sextant localization of prostate cancer:comparison between Magnetic Resonance Spectroscopic Imaging and 11C-Choline PET-CT.
2005 TESTA C.;SCHIAVINA R.;SALIZZONI E.;CORTI B.;KURHANEWICZ J.;BERTACCINI A.;MANFERRARI F.;BRUNOCILLA E.;CONCETTI S.;FRANCESCHELLI A.;MARTORANA G.;FRANCHI R.;MONETTI N.;FARSAD M.;FANTI S.;CANINI R.;COE M.;GRIGIONI W.F.;D'ERRICO A.;CASTELLUCCI P.;LODI R.;BARBIROLI B.
Controversies in diagnostic approaches to the indeterminate follicular thyroid nodule.
2005 Carpi A.; Nicolini A.; Gross MD.; Fig LM.; Shapiro B.; Fanti S.; Rampin L.; Polico C.; Rubello D.
11-C-choline PET/CT imaging for localization of recurrent prostate cancer
2005 Martorana, G.; Schiavina, R.; Brunocilla, E.; Bertaccini, A.; Manferrari, F.; Franceschelli, A.; Martinelli, A.; Franchi, R.; Monetti, N.; Castellucci, P.; Farsad, M.; Fanti S.; Grigioni, W.F.; Corti, B.; Fiorentino, M.; D'Errico, A.
The role of somatostatin receptor scintigraphy (Octreoscan) during follow-up of patients after bronchial carcinoid resection. A prospective study.
2005 A. BINI; M. GRAZIA; F. STELLA; F. PETRELLA; F. SELLITRI; S. FANTI; N. MONETTI; R. BAZZOCCHI
Ovarian Cancer Recurrence Detection: Does FDG PET/CT have an Added Value?
2005 C. Nanni; P. Castellucci; M. Farsad; R. Franchi; P. de Iaco; C. Zamagni; D. de Aloysio; F. Rosati; M. Sansovini; V. Ambrosini; D. Guidalotti; V. Allegri; A. Palucci; S. Fanti
Role of CT/PET in target volume definition for radiotherapy of patient with cancer
2005 A. Guido; F. Bunkheila; B. Rombi; M. Ntreta; s. Fanti; E. Barbieri
Value of PET-CT fusion imaging in avoiding potential pitfalls in the interpretation of (18)F-FDG accumulation in the distal oesophagus.
2005 Rampin L.; Nanni C.; Fanti S.; Rubello D.
Sextant localization of prostate cancer:comparison between Magnetic Resonance Spectroscopic Imaging and 11C-Choline PET-CT.
2005 Testa C.; Schiavina R.; Salizzoni E.; Corti B.; Kurhanewicz J.; Bertaccini A.; Manferrari F.; Brunocilla E.; Concetti S.; Franceschelli A.; Martorana G.; Franchi R.; Monetti N.; Farsad M.; Fanti S.; Canini R.; Coe M.; Grigioni W.F.; D'Errico A.; Castellucci P.; Lodi R.;Barbiroli B.
Inflammatory activity is still relevant in advanced stage of idiopathic pulmonary fibrosis.
2005 Mura M.; Belmonte G.; Fanti S.; Contini P.; Pacilli A.M.G.; Fasano L.; Zompatori M.; Schiavina m.; Fabbri M.
Sextant localization of prostate cancer with 11-C-choline PET/CT: comparison with three-dimensional proton MR spectroscopic imaging using step section histopathology as standard of references
2005 Martorana G.; Schiavina R.; Brunocilla E.; Bertaccini A.; Manferrari F.; Concetti S.; Franceschelli A.; Monetti N.; Castellucci P.; Farsad M.; Fanti S.; Canini R.; Salizzoni E.; Barbiroli B.; Lodi R.; Testa C.; Corti B.; Grigioni W.F.
Role of 18F-FDG PET-CT imaging for the detection of an unknown primary tumour: preliminary results in 21 patients.
2005 Nanni C.; Rubello D.; Castellucci P.; Farsad M.; Franchi R.; Toso S.; Barile C.; Rampin L.; Nibale O.; Fanti S.
18 F-FDG PET in malignant lymphoma: significance of positive findings
2005 Castellucci P.; Zinzani P.L.; Nanni C.; Farsad M.; Moretti A.; Alinari L.; Battista G.; Tani M.; Stefoni V.; Canini R.; Monetti N.; Rubello D.; Alavi A.; Franchi R.; Fanti S.
Focal lung uptake of 18F-fluorodeoxyglucose (18F-FDG) without computed tomography findings.
2005 Farsad M.; Ambrosini V.; Nanni C.; Castellucci P.; Boschi S.; Rubello D.; Fabbri M.; Franchi R.; Fanti S.
Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation.
2005 CASTELLUCCI P.; NANNI C.; FARSAD M.; ALINARI L.; ZINZANI P.; STEFONI V.; BATTISTA G.; VALENTINI D.; PETTINATO C.; MARENGO M.; BOSCHI S.; CANINI R.; BACCARANI M.; MONETTI N.; FRANCHI R.; RAMPIN L.; FANTI S.; RUBELLO D.
(18)F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients.
2005 Nanni C.; Rubello D.; Farsad M.; De Iaco P.; Sansovini M.; Erba P.; Rampin L.; Mariani G.; Fanti S.
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease. | CONTIN M; MARTINELLI P; MOCHI M; ALBANI F; RIVA R; SCAGLIONE C; DONDI M; FANTI S; PETTINATO C; BA...RUZZI A. | 2004-01-01 | CLINICAL NEUROPHARMACOLOGY | - | 1.01 Articolo in rivista | - |
18F-FDG PET early after radiotherapy in lymphoma patients. | CASTELLUCCI P; ZINZANI P; NANNI C; FARSAD M; MORETTI A; ALINARI L; BATTISTA G; PETTINATO C; MAREN...GO M; BOSCHI S; CANINI R; BACCARANI M.; MONETTI N; FANTI S. | 2004-01-01 | CANCER BIOTHERAPY & RADIOPHARMACEUTICALS | - | 1.01 Articolo in rivista | - |
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. | ZINZANI PL; FANTI S; BATTISTA G; TANI M; CASTELLUCCI P; STEFONI V; ALINARI L; FARSAD M; MUSURACA ...G; GABRIELE A; MARCHI E; NANNI C; CANINI R.; MONETTI N; BACCARANI M | 2004-01-01 | BRITISH JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
Does technetium-99m diethylenetriaminepentaacetate clearance predict the clinical course of idiopathic pulmonary fibrosis? | Mura M.; Belmonte G.; Fanti S.; Pacilli A.M.G.; Fasano L.; Zompatori M.; Schiavina M.; Fabbri Mario. | 2004-01-01 | CANADIAN RESPIRATORY JOURNAL | - | 1.01 Articolo in rivista | 185705.pdf |
Sextant localization of prostate cancer with 11-C-choline PET/CT: comparison with three-dimensional proton MR spectroscopic imaging using step section histopathology as standard of references | MARTORANA G.;SCHIAVINA R.;BRUNOCILLA E.;BERTACCINI A.;MANFERRARI F.;CONCETTI S.;FRANCESCHELLI A.;...MONETTI N.;CASTELLUCCI P.;FARSAD M.;FANTI S.;CANINI R.;SALIZZONI E.;BARBIROLI B.;LODI R.;TESTA C.;CORTI B.;GRIGIONI W.F. | 2005-01-01 | PROGRES EN UROLOGIE | - | 1.01 Articolo in rivista | - |
Sextant localization of prostate cancer:comparison between Magnetic Resonance Spectroscopic Imaging and 11C-Choline PET-CT. | TESTA C.;SCHIAVINA R.;SALIZZONI E.;CORTI B.;KURHANEWICZ J.;BERTACCINI A.;MANFERRARI F.;BRUNOCILLA... E.;CONCETTI S.;FRANCESCHELLI A.;MARTORANA G.;FRANCHI R.;MONETTI N.;FARSAD M.;FANTI S.;CANINI R.;COE M.;GRIGIONI W.F.;D'ERRICO A.;CASTELLUCCI P.;LODI R.;BARBIROLI B. | 2005-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
Controversies in diagnostic approaches to the indeterminate follicular thyroid nodule. | Carpi A.; Nicolini A.; Gross MD.; Fig LM.; Shapiro B.; Fanti S.; Rampin L.; Polico C.; Rubello D. | 2005-01-01 | BIOMÉDECINE & PHARMACOTHÉRAPIE | - | 1.01 Articolo in rivista | - |
11-C-choline PET/CT imaging for localization of recurrent prostate cancer | Martorana, G.; Schiavina, R.; Brunocilla, E.; Bertaccini, A.; Manferrari, F.; Franceschelli, A.; ...Martinelli, A.; Franchi, R.; Monetti, N.; Castellucci, P.; Farsad, M.; Fanti S.; Grigioni, W.F.; Corti, B.; Fiorentino, M.; D'Errico, A. | 2005-01-01 | EUROPEAN UROLOGY. SUPPLEMENTS | Karger: Elsevier Science | 4.01 Contributo in Atti di convegno | - |
The role of somatostatin receptor scintigraphy (Octreoscan) during follow-up of patients after bronchial carcinoid resection. A prospective study. | A. BINI; M. GRAZIA; F. STELLA; F. PETRELLA; F. SELLITRI; S. FANTI; N. MONETTI; R. BAZZOCCHI | 2005-01-01 | JOURNAL OF CARDIOVASCULAR SURGERY | - | 1.01 Articolo in rivista | - |
Ovarian Cancer Recurrence Detection: Does FDG PET/CT have an Added Value? | C. Nanni; P. Castellucci; M. Farsad; R. Franchi; P. de Iaco; C. Zamagni; D. de Aloysio; F. Rosati...; M. Sansovini; V. Ambrosini; D. Guidalotti; V. Allegri; A. Palucci; S. Fanti | 2005-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 4.02 Riassunto (Abstract) | - |
Role of CT/PET in target volume definition for radiotherapy of patient with cancer | A. Guido; F. Bunkheila; B. Rombi; M. Ntreta; s. Fanti; E. Barbieri | 2005-01-01 | CANCER IMAGING | - | 1.01 Articolo in rivista | - |
Value of PET-CT fusion imaging in avoiding potential pitfalls in the interpretation of (18)F-FDG accumulation in the distal oesophagus. | Rampin L.; Nanni C.; Fanti S.; Rubello D. | 2005-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.04 Replica / breve intervento (e simili) | - |
Sextant localization of prostate cancer:comparison between Magnetic Resonance Spectroscopic Imaging and 11C-Choline PET-CT. | Testa C.; Schiavina R.; Salizzoni E.; Corti B.; Kurhanewicz J.; Bertaccini A.; Manferrari F.; Bru...nocilla E.; Concetti S.; Franceschelli A.; Martorana G.; Franchi R.; Monetti N.; Farsad M.; Fanti S.; Canini R.; Coe M.; Grigioni W.F.; D'Errico A.; Castellucci P.; Lodi R.;Barbiroli B. | 2005-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
Inflammatory activity is still relevant in advanced stage of idiopathic pulmonary fibrosis. | Mura M.; Belmonte G.; Fanti S.; Contini P.; Pacilli A.M.G.; Fasano L.; Zompatori M.; Schiavina m....; Fabbri M. | 2005-01-01 | RESPIROLOGY | - | 1.01 Articolo in rivista | - |
Sextant localization of prostate cancer with 11-C-choline PET/CT: comparison with three-dimensional proton MR spectroscopic imaging using step section histopathology as standard of references | Martorana G.; Schiavina R.; Brunocilla E.; Bertaccini A.; Manferrari F.; Concetti S.; Franceschel...li A.; Monetti N.; Castellucci P.; Farsad M.; Fanti S.; Canini R.; Salizzoni E.; Barbiroli B.; Lodi R.; Testa C.; Corti B.; Grigioni W.F. | 2005-01-01 | PROGRES EN UROLOGIE | - | 4.02 Riassunto (Abstract) | - |
Role of 18F-FDG PET-CT imaging for the detection of an unknown primary tumour: preliminary results in 21 patients. | Nanni C.; Rubello D.; Castellucci P.; Farsad M.; Franchi R.; Toso S.; Barile C.; Rampin L.; Nibal...e O.; Fanti S. | 2005-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
18 F-FDG PET in malignant lymphoma: significance of positive findings | Castellucci P.; Zinzani P.L.; Nanni C.; Farsad M.; Moretti A.; Alinari L.; Battista G.; Tani M.; ...Stefoni V.; Canini R.; Monetti N.; Rubello D.; Alavi A.; Franchi R.; Fanti S. | 2005-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
Focal lung uptake of 18F-fluorodeoxyglucose (18F-FDG) without computed tomography findings. | Farsad M.; Ambrosini V.; Nanni C.; Castellucci P.; Boschi S.; Rubello D.; Fabbri M.; Franchi R.; ...Fanti S. | 2005-01-01 | NUCLEAR MEDICINE COMMUNICATIONS | - | 1.01 Articolo in rivista | - |
Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation. | CASTELLUCCI P.; NANNI C.; FARSAD M.; ALINARI L.; ZINZANI P.; STEFONI V.; BATTISTA G.; VALENTINI D....; PETTINATO C.; MARENGO M.; BOSCHI S.; CANINI R.; BACCARANI M.; MONETTI N.; FRANCHI R.; RAMPIN L.; FANTI S.; RUBELLO D. | 2005-01-01 | NUCLEAR MEDICINE COMMUNICATIONS | - | 1.01 Articolo in rivista | - |
(18)F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients. | Nanni C.; Rubello D.; Farsad M.; De Iaco P.; Sansovini M.; Erba P.; Rampin L.; Mariani G.; Fanti S. | 2005-01-01 | EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile